The world is facing a growing crisis of microbial infections, where resistant strains are rapidly outpacing the development of new therapeutics. In an effort to combat this, the polymer community is developing new ways to improve upon drug delivery, synthesizing novel antimicrobial polymers, and using polymer technology to harness combination therapies. This review focuses primarily on the use of polymers to treat both bacterial and fungal infections in recent years. A bevy of work has illustrated that polymer technologies can have a huge impact in treating bacterial infections. However, harnessing polymers to deliver antifungals or as stand-alone therapeutics lags far behind that of interventions for bacterial infections. Fungal infections can be crippling to both human health and the agricultural community, making this area ripe for drug delivery technologies. This review describes recent work and highlights opportunities for bacterial and fungal treatment using soft matter.
Keywords: bacterial and fungal infections; microbial infections; multidrug resistant bacteria; nanoparticle drug delivery; polymers.